The importance of whey protein levels of Klotho and fibroblast growth of factor-23 (fgf-23) as early diagnostic markers of chronic kidney damage

The purpose of the study is to investigate the clinical significance of determination of serum FGF-23 and Klotho in patients with different stages of chronic kidney disease (CKD). Materials and Methods: The study included 70 patients with CKD stages 1–5D (30 men and 40 women, mean age 41,0–6,7 years...

Full description

Bibliographic Details
Published in:	Сеченовский вестник
Main Authors:	L. Yu. Milovanova, S. Yu. Milovanova, D. V. Kryukova, S. V. Moiseev, L. V. Kozlovskaya
Format:	Article
Language:	Russian
Published:	Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University) 2014-06-01
Subjects:	ckd fgf-23 klotho
Online Access:	https://www.sechenovmedj.com/jour/article/view/742

Similar Items

Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration
by: L Yu Milovanova, et al.
Published: (2018-06-01)

Fibroblast growth factor 23 is independently associated with renal magnesium handling in patients with chronic kidney disease
by: Teodora V. Grigore, et al.
Published: (2023-01-01)

Significance of the morphogenetic proteins FGF-23 and Klotho as predictors of prognosis of chronic kidney disease
by: L Iu Milovanova, et al.
Published: (2014-04-01)

Bone mineral disorder in chronic kidney disease: Klotho and FGF23; cardiovascular implications
by: Laura Salanova Villanueva, et al.
Published: (2016-07-01)

The Complexity of FGF23 Effects on Cardiomyocytes in Normal and Uremic Milieu
by: Andreja Figurek, et al.
Published: (2021-05-01)

Enfermedad óseo mineral relacionada con la enfermedad renal crónica: Klotho y FGF23; implicaciones cardiovasculares
by: Laura Salanova Villanueva, et al.
Published: (2016-07-01)

Relationships of serum FGF23 and α-klotho with atherosclerosis in patients with type 2 diabetes mellitus
by: Jiao Bi, et al.
Published: (2024-04-01)

FGF23, Hypophosphatemia, and Emerging Treatments
by: Erik A Imel, et al.
Published: (2019-08-01)

The effect of Aerobic training on Klotho-FGF23 axis and arterial calcification in type 2 diabetic Postmenopausal women
by: Hamid Rajabi, et al.
Published: (2020-08-01)

Diagnostic potential of increased Klotho and FGF23 protein concentrations after myocardial infarction in patients with acute coronary syndrome
by: Agnieszka Olejnik, et al.
Published: (2025-08-01)

Blood concentrations of α-Klotho and FGF-23 exhibit no correlation with bone mineral density in elderly individuals
by: Karina Moura Sawada, et al.
Published: (2024-09-01)

Expression of FGF23 and α-KLOTHO in Normal Human Kidney Development and Congenital Anomalies of the Kidney and Urinary Tract (CAKUT)
by: Patricija Bajt, et al.
Published: (2025-06-01)

Serum α-Klotho and fibroblast growth factor 23 levels are not associated with non-proliferative diabetic retinopathy in type 1 diabetes mellitus
by: Can Oner, et al.
Published: (2024-02-01)

The Clinical Value of Klotho and FGF23 in Cardiac Valve Calcification Among Patients with Chronic Kidney Disease
by: Chen Y, et al.
Published: (2021-03-01)

Clinical Potential of Targeting Fibroblast Growth Factor‐23 and αKlotho in the Treatment of Uremic Cardiomyopathy
by: Jonathan P. Law, et al.
Published: (2020-04-01)

FGF23-Klotho内分泌轴对脑血管及卒中的影响综述 A Review of the Effects of the FGF23-Klotho Endocrine Axis on Blood Vessels of Brain and Stroke
by: 宋晓1，卢克良1，吴春艳2 (SONG Xiao1, LU Keliang1, WU Chunyan2 )
Published: (2024-04-01)

Association between Soluble α-Klotho Protein and Metabolic Syndrome in the Adult Population
by: Yung-Wen Cheng, et al.
Published: (2022-01-01)

A potential link between fibroblast growth factor-23 and the progression of AKI to CKD
by: Yinghui Lu, et al.
Published: (2023-04-01)

The stability and variability of serum and plasma fibroblast growth factor-23 levels in a haemodialysis cohort
by: Matthew J. Damasiewicz, et al.
Published: (2018-11-01)

Role of sclerostin, fibroblast growth factor-23, and Klotho in hemodialysis patients
by: Azza A I. Elmenyawi, et al.
Published: (2019-01-01)

Klotho/FGF23 axis mediates high phosphate‐induced vascular calcification in vascular smooth muscle cells via Wnt7b/β‐catenin pathway
by: Yan‐Xia Chen, et al.
Published: (2019-07-01)

Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho
by: Alexandra S. Aaldijk, et al.
Published: (2023-05-01)

Erythropoietin and a hypoxia‐inducible factor prolyl hydroxylase inhibitor (HIF‐PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)
by: Megan L. Noonan, et al.
Published: (2020-06-01)

Klotho’s Impact on Cardiovascular Disease, Fractures, and Mortality in Hemodialysis
by: Akio Nakashima, et al.
Published: (2025-10-01)

AMP‐dependent kinase stimulates the expression of αKlotho
by: Julia Vogt, et al.
Published: (2024-10-01)

Association of fibroblast growth factor 23 and α-klotho in hemodialysis patients during administration of ferric citrate hydrate: post hoc analysis of ASTRIO study
by: Kyoko Ito, et al.
Published: (2021-11-01)

The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients
by: Aneta Cymbaluk-Płoska, et al.
Published: (2020-06-01)

Klotho protein, fibroblast growth factor 23, and sclerostin in chronic heart failure: literature review
by: Amina M. Alieva, et al.
Published: (2024-04-01)

Expression of fibroblast growth factor 23 (FGF23) and αKlotho in two commercial laying hen strains fed with and without dietary mineral P supplements before and after the onset of the laying phase
by: Leonie Meier, et al.
Published: (2025-11-01)

Editorial: Endocrine and Paracrine Role of FGF23 and Klotho in Health and Disease
by: Reinhold G. Erben
Published: (2019-01-01)

Variation in the fibroblast growth factor 23 (FGF23) gene associates with serum FGF23 and bone strength in infants
by: Maria Enlund-Cerullo, et al.
Published: (2023-05-01)

Fibroblast Growth Factor-23 (FGF-23) in Dogs—Reference Interval and Correlation with Hematological and Biochemical Parameters
by: Sandra Lapsina, et al.
Published: (2023-10-01)

Predictive value of circulating fibroblast growth factor-23 and Klotho on protein-energy wasting in patients undergoing hemodialysis
by: Xiaoling Zhou, et al.
Published: (2025-01-01)

Phosphopenic form of osteomalacia in a patient with FGF23 producing tumor
by: A. S. Pushkareva, et al.
Published: (2022-05-01)

Vitamin D Actions: The Lung Is a Major Target for Vitamin D, FGF23, and Klotho
by: Ghislaine Gayan‐Ramirez, et al.
Published: (2021-12-01)

Sucroferric oxyhydroxide decreases serum phosphorus level and fibroblast growth factor 23 and improves renal anemia in hemodialysis patients
by: Hisato Shima, et al.
Published: (2018-06-01)

Assessment of Fibroblast Growth Factor- 23 and Klotho Protein in Children with Steroid-Sensitive Nephrotic Syndrome and Steroid-Resistance Nephrotic Syndrome
by: Ahmed Hatem Alwan, et al.
Published: (2025-09-01)

Role of serum fibroblast growth factor-23 and Klotho level in COVID-19 infection-related mortality: a prospective study
by: Davut Akin, et al.
Published: (2024-12-01)

FGF23 and primary hyperparathyroidism: is there a link?
by: Stefana Catalina Bilha, et al.
Published: (2020-08-01)

The relationship between Fibroblast Growth Factor 23 (FGF23) and cardiac MRI findings following primary PCI in patients with acute first time STEMI
by: Inga Strand Thorsen, et al.
Published: (2021-04-01)